Nebula Research & Development LLC

SEC CIK: 0001792635
Latest filing: May 15, 2026

SEC filings (opens in a new tab)

TVTX holding history

Travere Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TVTX overview All 13F holders of TVTX Full Q1 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of TVTX by Nebula Research & Development LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−11,508−100.0%	Sold out	Holders
Q3 2024	11,508	$161.0K	<0.1%	+11,508	New	Holders
Q2 2024	0	$0	0.0%	−12,698−100.0%	Sold out	Holders
Q1 2024	12,698	$97.9K	<0.1%	+12,698	New	Holders